Molecular Characterization, Pathology, and Experimental Pathogenicity of FAdV-11-Associated Inclusion Body Hepatitis in Broiler Chickens
Poultry · 17.11.2026 · 5 (6) · 80
DOI: 10.3390/poultry5060080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Poultry, online erschienen am 17.11.2026. Verfasst von Muntasir Ashraf Wani und 11 weiteren Autor:innen. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Holistic Agriculture Development Programme (HADP) Project 25.
Abstract (Originalsprache)
Fowl adenoviruses (FAdVs) are key poultry pathogens associated with inclusion body hepatitis (IBH), causing severe hepatic injury and mortality in young chickens. This study investigated IBH outbreaks in commercial broiler flocks in the Kashmir Valley, India, during 2022–2023, performing field screening, pathological examination, molecular and phylogenetic characterization, and experimental pathogenicity assessment of the circulating strain. Across 25 suspected outbreaks comprising 27,353 birds, 3533 deaths were recorded (overall observed mortality rate: 12.92%). Polymerase chain reaction (PCR) screening of the 200 pooled tissue samples (liver, heart, kidney, and spleen) targeting the Hexon gene amplified an ~897-bp product, detecting FAdV in 144 samples (72%) across 18 of the 25 investigated outbreaks (72%). Gross pathological examination revealed hepatomegaly, hepatic mottling, pallor, friability, petechial haemorrhages in the liver and kidneys, and splenomegaly. Histopathologically, tissues exhibited hepatocellular degeneration and necrosis, heterophilic infiltration, congestion, basophilic intranuclear inclusion bodies, splenic lymphoid depletion, glomerular atrophy, and myocardial fiber disruption. Sequence analysis revealed 98.72% nucleotide identity with the FAdV-11 isolate (GenBank accession number HQ697595.1), while phylogenetic analysis supported classification of the virus as FAdV-11 (species D) and established its relationship with Asian isolates. Experimental pathogenicity evaluation in sixty 14-day-old specific-pathogen-free (SPF) chicks inoculated intramuscularly (IM) and/or (IP) with 105 TCID50/mL (0.2 mL virus suspension, equivalent to 2×104 TCID50 per bird) resulted in 100% mortality by day 6 in IM-inoculated birds. IP-inoculated birds underwent scheduled serial euthanasia for pathological evaluation; due to differing termination schedules, mortality outcomes were not directly comparable between routes. Experimental infection induced clinical and pathological changes, haematological alterations, elevated serum liver enzyme activities, and hepatic viral DNA presence. To our knowledge, this study provides one of the first molecular and pathological documentations of FAdV-11-associated IBH in commercial broilers in this region.
Förderung
- Holistic Agriculture Development Programme (HADP) Project 25
Zitieren
APA
Wani, M. A., Beigh, A. B., Maqbool, Y., Mir, M. S., Kamil, S. A., Shah, S. A., Shafi, M., Shabir, N., Dar, P. A., Khan, A. A., Goud, S. C., & Wani, A. K. (2026). Molecular Characterization, Pathology, and Experimental Pathogenicity of FAdV-11-Associated Inclusion Body Hepatitis in Broiler Chickens. Poultry, 5(6), 80. https://doi.org/10.3390/poultry5060080
Vancouver
Wani MA, Beigh AB, Maqbool Y, Mir MS, Kamil SA, Shah SA, et al. Molecular Characterization, Pathology, and Experimental Pathogenicity of FAdV-11-Associated Inclusion Body Hepatitis in Broiler Chickens. Poultry. 2026;5(6):80. doi:10.3390/poultry5060080
BibTeX
@article{Wani2026,
author = {Wani, Muntasir Ashraf and Beigh, Akeel Bashir and Maqbool, Yaqoota and Mir, Masood Saleem and Kamil, Shayaib Ahmad and Shah, Showkat Ahmad and Shafi, Majid and Shabir, Nadeem and Dar, Parvaiz Ahmad and Khan, Azmat Alam and Goud, Sharath Chandra and Wani, Atif Khurshid},
title = {Molecular Characterization, Pathology, and Experimental Pathogenicity of FAdV-11-Associated Inclusion Body Hepatitis in Broiler Chickens},
journal = {Poultry},
year = {2026},
volume = {5},
number = {6},
pages = {80},
doi = {10.3390/poultry5060080}
}
EUVIMED